VKH
OGEN icon

Virtu KCG Holdings’s Oragenics OGEN Stock Holding History

Virtu KCG Holdings’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$57K Buy
9
+7
+350% +$51.9K ﹤0.01% 2555
2017
Q1 		$12K Hold
2
– – ﹤0.01% 3015
2016
Q4 		$16K Buy
+2
New +$18.6K ﹤0.01% 3257
2015
Q4 		– Sell
-2
Closed -$53K – 3812
2015
Q3 		$53K Buy
+2
New +$81.5K ﹤0.01% 2987
2015
Q2 		– Sell
-1
Closed -$12K – 3628
2015
Q1 		$12K Buy
+1
New +$17.5K ﹤0.01% 3001
2014
Q1 		– Sell
-1
Closed -$49K – 3911
2013
Q4 		$49K Buy
+1
New +$52.2K ﹤0.01% 3603

Other funds holding OGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu KCG Holdings's OGEN Position: Q2 2017 in Review

Virtu KCG Holdings increased its Oragenics (OGEN) stake by 350% in Q2 2017, buying an estimated $51.9K and bringing the position to 9 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #2555.

Virtu KCG Holdings first reported a position in OGEN in Q4 2013 and has held it in 6 quarters since. 12 funds tracked by Wall St. Rank hold OGEN as of Q2 2017.

  • Virtu KCG Holdings held 9 shares of Oragenics worth $57K as of Q2 2017.
  • Virtu KCG Holdings bought 7 Oragenics shares in Q2 2017, an estimated $51.9K.
  • Oragenics made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2555 holding.
  • Virtu KCG Holdings first reported a position in Oragenics in Q4 2013 and has held it in 6 quarters since.
  • 12 funds tracked by Wall St. Rank held Oragenics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.